USPSTF recommends aspirin for prevention of colorectal cancer
the ONA take:
For the first time, the United States Preventive Services Task Force (USPSTF) has issued a broad recommendation to take aspirin to prevent colorectal cancer.
In the draft report, the task force found that low-dose or baby aspirin can help prevent heart attacks, stroke, and colorectal cancer, particularly in high-risk people in their 50’s.
An analysis on colorectal cancer found that aspirin use reduced colorectal cancer-related deaths by 33% and reduced colon cancer incidence by 40%; however, people need to take aspirin for at least 5 to 10 years in order to have a benefit.
“No major health organization has previously recommended the use of aspirin to prevent cancer,” Dr. Eric Jacobs of the American Cancer Society said. “This is a new approach that makes a great deal of sense.”
However, not everyone feels positively about these new recommendations. “People still need to be screened,” Dr. David Johnson of the United Stated Multi-Society Task Force on Colorectal Cancer said. “I have major reservations that the message will be, ‘I take aspirin, so I don’t need to be screened.’”
According to the American Cancer Society, colorectal cancer is the third leading cause of cancer-related deaths in the United States in men and women separately and the second leading cause when combined.
The USPSTF has issued a broad recommendation to take aspirin to prevent colorectal cancer.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|